Hydroxocobalamin is a medication used in the management and treatment of vitamin B12 deficiency and acute cyanide toxicity. It is in the anti-anemic class of drugs. This activity outlines the indications, action, and contraindications for hydroxocobalamin as a valuable agent in managing macrocytic anemia and acute cyanide toxicity. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team) in the treatment of patients with vitamin B12 deficiency and related conditions.

**Objectives:**
- Identify the mechanism of action of hydroxocobalamin.
- Describe the potential adverse effects of hydroxocobalamin.
- Review the appropriate monitoring for patients using hydroxocobalamin.
- Explain the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients receiving hydroxocobalamin.